Log In
Print
BCIQ
Print
Print this Print this
 

PWT33597

  Manage Alerts
Collapse Summary General Information
Company Pathway Therapeutics Inc.
DescriptionDual inhibitor of Phosphoinositide 3-kinase (PI3K) alpha and mammalian target of rapamycin (mTOR; FRAP; RAFT1)
Molecular Target Phosphoinositide 3-kinase (PI3K) alpha ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor; Phosphoinositide 3-kinase (PI3K) alpha inhibitor
Latest Stage of DevelopmentPhase I
IndicationSolid tumors
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today